IL80659A - Modified tissue plasminogen activators,their preparation and pharmaceutical compositions containing them - Google Patents
Modified tissue plasminogen activators,their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL80659A IL80659A IL80659A IL8065986A IL80659A IL 80659 A IL80659 A IL 80659A IL 80659 A IL80659 A IL 80659A IL 8065986 A IL8065986 A IL 8065986A IL 80659 A IL80659 A IL 80659A
- Authority
- IL
- Israel
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- tissue plasminogen
- plasminogen activators
- Prior art date
Links
- 102000001938 Plasminogen Activators Human genes 0.000 title 1
- 108010001014 Plasminogen Activators Proteins 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229940127126 plasminogen activator Drugs 0.000 title 1
- 101000801481 Homo sapiens Tissue-type plasminogen activator Proteins 0.000 abstract 1
- 230000004988 N-glycosylation Effects 0.000 abstract 1
- 108050006955 Tissue-type plasminogen activator Proteins 0.000 abstract 1
- 102100033571 Tissue-type plasminogen activator Human genes 0.000 abstract 1
- 239000003527 fibrinolytic agent Substances 0.000 abstract 1
- 230000013595 glycosylation Effects 0.000 abstract 1
- 238000006206 glycosylation reaction Methods 0.000 abstract 1
- 102000047823 human PLAT Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB858528321A GB8528321D0 (en) | 1985-11-18 | 1985-11-18 | Modified fibrinolytic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL80659A0 IL80659A0 (en) | 1987-02-27 |
| IL80659A true IL80659A (en) | 1991-12-15 |
Family
ID=10588363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL80659A IL80659A (en) | 1985-11-18 | 1986-11-17 | Modified tissue plasminogen activators,their preparation and pharmaceutical compositions containing them |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0225286B1 (2) |
| JP (1) | JPS62272976A (2) |
| KR (1) | KR920007666B1 (2) |
| AT (1) | ATE78514T1 (2) |
| AU (1) | AU598490B2 (2) |
| DE (1) | DE3686136T2 (2) |
| DK (1) | DK174977B1 (2) |
| ES (1) | ES2043607T3 (2) |
| FI (1) | FI91160C (2) |
| GB (1) | GB8528321D0 (2) |
| GR (1) | GR3006041T3 (2) |
| IE (1) | IE57866B1 (2) |
| IL (1) | IL80659A (2) |
| NO (1) | NO175266C (2) |
| NZ (1) | NZ218305A (2) |
| PT (1) | PT83752B (2) |
| ZA (1) | ZA868689B (2) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES8702945A1 (es) * | 1984-10-01 | 1987-01-16 | Integrated Genetics Inc | Un metodo de producir activador de plasminogeno de tejido uterino humano |
| DE3684680D1 (de) * | 1985-12-23 | 1992-05-07 | Chiron Corp | Peptidplasminogenaktivatoren. |
| US5002887A (en) * | 1986-01-31 | 1991-03-26 | Genetics Institute, Inc. | Truncated thrombolytic proteins |
| US5258298A (en) * | 1986-01-31 | 1993-11-02 | Genetics Institute, Inc. | Deletion and glycosylation mutant of human tissue plasminogen activator |
| US5837518A (en) * | 1986-01-31 | 1998-11-17 | Genetics Institute, Inc. | Thrombolytic proteins |
| US5589361A (en) * | 1986-03-18 | 1996-12-31 | Genentech, Inc. | Human tissue-type plasminogen activator variant |
| IE81073B1 (en) * | 1986-03-18 | 2000-01-12 | Genentech Inc | Modified human tissue-type plasminogen activator and its preparation |
| US5047241A (en) * | 1986-07-11 | 1991-09-10 | American Home Products Corporation | Tris-Kringle plasminogen activator with novel K2 insert |
| EP0276846A3 (en) * | 1987-01-29 | 1989-07-26 | Zymogenetics, Inc. | Colony-stimulating factor derivatives |
| JPH084501B2 (ja) * | 1987-03-20 | 1996-01-24 | エーザイ株式会社 | 糖鎖に関する変異ｔＰＡ |
| SE8702562L (sv) * | 1987-06-18 | 1988-12-19 | Kabigen Ab | Nya fibrinolytiska enzymer |
| US6682733B1 (en) * | 1987-06-18 | 2004-01-27 | Roche Diagnostics, Gmbh | Fibrinolytic enzymes |
| US5266474A (en) * | 1987-06-24 | 1993-11-30 | Genentech, Inc. | Balanced inducible transcription system |
| US5302390A (en) * | 1987-07-01 | 1994-04-12 | Beecham Group Plc | Hybrid proteins of human plasminogen and human t-PA, pharmaceutical compositions and methods of treatment |
| AU2081788A (en) * | 1987-07-06 | 1989-01-30 | Genetics Institute Inc. | Novel thrombolytic proteins |
| AU1893988A (en) * | 1987-07-13 | 1989-01-19 | Collaborative Research Inc. | Nonglycosylated plasminogen activator and method of preparation |
| US5346824A (en) * | 1988-05-20 | 1994-09-13 | Genentech, Inc. | DNA encoding variants of tissue plasminogen activators and expression vectors and hosts thereof |
| IL90146A (en) * | 1988-05-20 | 1994-10-07 | Genentech Inc | Glycosylation derivatives of tissue plasminogen activator |
| US5270198A (en) * | 1988-05-20 | 1993-12-14 | Genentech, Inc. | DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells |
| US5258180A (en) * | 1988-09-02 | 1993-11-02 | Genetech, Inc. | Tissue plasminogen activator having fibrin specific properties and deletion of amino acids 466-970, compositions and methods of treatment |
| US5108901A (en) * | 1988-09-02 | 1992-04-28 | Genentech, Inc. | Tissue plasminogen activator having zymogenic or fibrin specific properties |
| US5262170A (en) * | 1988-09-02 | 1993-11-16 | Genentech, Inc. | Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells |
| US5714145A (en) * | 1988-09-02 | 1998-02-03 | Genentech, Inc. | Tissue plasminogen activator having zymogenic or fibrin specific properties |
| WO1991015235A1 (en) * | 1990-03-30 | 1991-10-17 | Survival Technology, Inc. | t-PA ENHANCER PROFILE |
| US5242688A (en) * | 1990-12-24 | 1993-09-07 | Eli Lilly And Company | Method of treating thromboembolic disorders by administration of diglycosylated t-pa variants |
| JP3559559B2 (ja) * | 1992-06-03 | 2004-09-02 | ジェネンテク，インコーポレイテッド | 向上した治療特性を有する組織プラスミノーゲン活性化因子グリコシル化変異体 |
| CN1113389A (zh) * | 1993-08-04 | 1995-12-13 | 西巴-盖尔基股份公司 | 高分子量的脱硫水蛭素 |
| US6706504B1 (en) | 1996-11-12 | 2004-03-16 | The Scripps Research Institute | Tissue type plasminogen activator (t-PA) variants: compositions and methods of use |
| EP2861614B1 (en) * | 2012-06-14 | 2016-11-30 | Portola Pharmaceuticals, Inc. | METHOD FOR PURIFICATION OF RECOMBINANT FACTOR Xa DERIVATIVES |
| CN120040044A (zh) * | 2025-04-11 | 2025-05-27 | 西安热工研究院有限公司 | 一种scal型间冷循环水旁路净化装置及方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA833174B (en) * | 1982-05-05 | 1984-08-29 | Genentech Inc | Human tissue plasminogen activator |
| IL68561A (en) * | 1982-05-05 | 1991-01-31 | Genentech Inc | Preparation of polypeptide with human tissue plasminogen activator function,processes for making it,and dna and transformed cell intermediates thereof |
| EP0125254A1 (en) * | 1982-10-28 | 1984-11-21 | Beecham Group Plc | Enzyme derivatives and their use in the treatment of thrombosis |
| IE56716B1 (en) * | 1983-01-19 | 1991-11-20 | Genentech Inc | Method for producing human tpa and expression vectors therefor |
| ES8702945A1 (es) * | 1984-10-01 | 1987-01-16 | Integrated Genetics Inc | Un metodo de producir activador de plasminogeno de tejido uterino humano |
| DE3537176C2 (de) * | 1984-10-18 | 1994-06-09 | Zymogenetics Inc | Gewebeplasminogenaktivator und Verfahren zu seiner Herstellung |
| JPH0811066B2 (ja) * | 1985-09-30 | 1996-02-07 | インテグレーテッド・ジエネティックス・インコーポレーテッド | 組換えｄｎａが生産するヒト子宮プラスミノ−ゲンアクチベ−タ− |
-
1985
- 1985-11-18 GB GB858528321A patent/GB8528321D0/en active Pending
-
1986
- 1986-11-13 DE DE8686810518T patent/DE3686136T2/de not_active Expired - Lifetime
- 1986-11-13 AT AT86810518T patent/ATE78514T1/de not_active IP Right Cessation
- 1986-11-13 EP EP86810518A patent/EP0225286B1/en not_active Expired - Lifetime
- 1986-11-13 ES ES86810518T patent/ES2043607T3/es not_active Expired - Lifetime
- 1986-11-14 FI FI864654A patent/FI91160C/fi not_active IP Right Cessation
- 1986-11-17 IL IL80659A patent/IL80659A/xx not_active IP Right Cessation
- 1986-11-17 DK DK198605491A patent/DK174977B1/da not_active IP Right Cessation
- 1986-11-17 NZ NZ218305A patent/NZ218305A/en unknown
- 1986-11-17 IE IE3028/86A patent/IE57866B1/en not_active IP Right Cessation
- 1986-11-17 AU AU65200/86A patent/AU598490B2/en not_active Expired
- 1986-11-17 NO NO864569A patent/NO175266C/no not_active IP Right Cessation
- 1986-11-17 ZA ZA868689A patent/ZA868689B/xx unknown
- 1986-11-17 PT PT83752A patent/PT83752B/pt not_active IP Right Cessation
- 1986-11-17 JP JP61272033A patent/JPS62272976A/ja active Pending
- 1986-11-18 KR KR1019860009732A patent/KR920007666B1/ko not_active Expired
-
1992
- 1992-10-22 GR GR920401405T patent/GR3006041T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GR3006041T3 (2) | 1993-06-21 |
| DK549186A (da) | 1987-05-19 |
| IE57866B1 (en) | 1993-05-05 |
| DE3686136T2 (de) | 1992-12-17 |
| EP0225286B1 (en) | 1992-07-22 |
| PT83752B (pt) | 1989-06-30 |
| KR920007666B1 (ko) | 1992-09-14 |
| IE863028L (en) | 1987-05-18 |
| PT83752A (en) | 1986-12-01 |
| DK549186D0 (da) | 1986-11-17 |
| DK174977B1 (da) | 2004-04-05 |
| ES2043607T3 (es) | 1994-01-01 |
| FI864654A0 (fi) | 1986-11-14 |
| EP0225286A3 (en) | 1987-10-07 |
| AU6520086A (en) | 1987-05-21 |
| ATE78514T1 (de) | 1992-08-15 |
| FI91160B (fi) | 1994-02-15 |
| KR870005094A (ko) | 1987-06-04 |
| FI91160C (fi) | 1994-05-25 |
| NZ218305A (en) | 1990-01-29 |
| NO864569D0 (no) | 1986-11-17 |
| NO175266C (no) | 1994-09-28 |
| ZA868689B (en) | 1987-06-24 |
| FI864654L (fi) | 1987-05-19 |
| EP0225286A2 (en) | 1987-06-10 |
| JPS62272976A (ja) | 1987-11-27 |
| IL80659A0 (en) | 1987-02-27 |
| GB8528321D0 (en) | 1985-12-24 |
| NO175266B (no) | 1994-06-13 |
| AU598490B2 (en) | 1990-06-28 |
| NO864569L (no) | 1987-05-19 |
| DE3686136D1 (de) | 1992-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL80659A0 (en) | Modified tissue plasminogen activators,their preparation and pharmaceutical compositions containing them | |
| GB2189249B (en) | Modified human tissue-type plasminogen activator and its preparation | |
| NZ216306A (en) | Pharmaceutical compositions containing tissue plasminogen activator | |
| EP0196920A3 (en) | Degraded species of tissue-type plasminogen activator, pharmaceutical composition and method of preparation | |
| NZ216307A (en) | Pharmaceutical compositions containing tissue plasminogen activator | |
| IE882836L (en) | Antiviral preparations | |
| IL86909A0 (en) | Hybrid plasminogen activator,dna coding therefor,derivatives of said plasminogen activator and pharmaceutical compositions containing said plasminogen activator or said derivatives | |
| AU2131792A (en) | Novel human tissue-type plasminogen activator variant | |
| AU609337B2 (en) | Tissue plasminogen activator (t-pa) muteins and processes for the preparation thereof | |
| AU608232C (en) | Modified tissue plasminogen activator | |
| IE901848L (en) | Derivative of tissue-type plasminogen activator | |
| AU7696087A (en) | Recombinant human tissue plasminogen activator composition | |
| ZA871982B (en) | Human tissue-type plasminogen activator polypeptides | |
| IE860355L (en) | Modified tissue-type plasminogen activator | |
| ZA887950B (en) | Human t-pa(u-pa)substitution-mutant proteins,recombinant dna coding therefor,transfected host cells,preparation of the mutant proteins,and pharmaceutical compositions | |
| AU7554687A (en) | Modified tissue plasminogen activator |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| HC | Change of name of proprietor(s) | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| EXP | Patent expired |